Evidence map›Paper›PMID 22948381›Full record

SynthesisTranslational psychiatry2012

Replication and meta-analysis of TMEM132D gene variants in panic disorder.

A Erhardt, N Akula, J Schumacher, D Czamara, N Karbalai, B Müller-Myhsok, O Mors, A Borglum, A S Kristensen, D P D Woldbye and 20 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Translational psychiatry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 6 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 6 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Genome-wide association study of shared liability to anxiety disorders in Army STARRS.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2020
    Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Connecting genomic and proteomic signatures of amyloid burden in the brain.medRxiv : the preprint server for health sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Genetic and epigenetic analyses of panic disorder in the post-GWAS era.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 18 institutions in 8 countries.

A ErhardtMax-Planck-Institute of Psychiatry, Munich, Germany. erhardt@mpipsykl.mpg.de
N Akula
J Schumacher
D Czamara
N Karbalai
B Müller-Myhsok
O Mors
A Borglum
A S Kristensen
D P D Woldbye
P Koefoed
E Eriksson
E Maron
A Metspalu
J Nurnberger
R A Philibert
J Kennedy
K Domschke
A Reif
J Deckert
T Otowa
Y Kawamura
H Kaiya
Y Okazaki
H Tanii
K Tokunaga
T Sasaki
J P A Ioannidis
F J McMahon
E B Binder
Max Planck Institute of Psychiatry · DEAarhus University · DKThe University of Tokyo · JPUniversity of Würzburg · DEUniversity of Copenhagen · DKEstonian Biocentre · EEIndiana University – Purdue University Indianapolis · USMie University · JPNational Institute of Mental Health · USPanasonic (Japan) · JPStanford University · USTokyo Metropolitan Matsuzawa Hospital · JPUnited States Department of Health and Human Services · USUniversity of Bonn · DEUniversity of Gothenburg · SEUniversity of Iowa · USUniversity of Tartu · EEUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recent genome-wide association study in patients with panic disorder (PD) identified a risk haplotype consisting of two single-nucleotide polymorphisms (SNPs) (rs7309727 and rs11060369) located in intron 3 of TMEM132D to be associated with PD in three independent samples. Now we report a subsequent confirmation study using five additional PD case-control samples (n = 1670 cases and n = 2266 controls) assembled as part of the Panic Disorder International Consortium (PanIC) study for a total of 2678 cases and 3262 controls in the analysis. In the new independent samples of European ancestry (EA), the association of rs7309727 and the risk haplotype rs7309727-rs11060369 was, indeed, replicated, with the strongest signal coming from patients with primary PD, that is, patients without major psychiatric comorbidities (n = 1038 cases and n = 2411 controls). This finding was paralleled by the results of the meta-analysis across all samples, in which the risk haplotype and rs7309727 reached P-levels of P = 1.4e-8 and P = 1.1e-8, respectively, when restricting the samples to individuals of EA with primary PD. In the Japanese sample no associations with PD could be found. The present results support the initial finding that TMEM132D gene contributes to genetic susceptibility for PD in individuals of EA. Our results also indicate that patient ascertainment and genetic background could be important sources of heterogeneity modifying this association signal in different populations.

Indexed as

AdultFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHaplotypesHumansMaleMembrane ProteinsPanic DisorderPolymorphism, Single NucleotideWhite PeopleMembrane Proteins

Identifiers

PMID22948381
PMCPMC3565207
OpenAlexW2132823987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.